Sreening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years

European Journal of Epidemiology

Volumn 19, Issue 10, 2004, Pages 973-978

  Denis, François ^a   Ranger Rogez, Sylvie ^a   Alain, Sophie ^a   Mounier, Marcelle ^a   Debrock, Caroline ^a   Wagner, Anne ^a   Delpeyroux, Christian ^a   Tabaste, Jean ^b   Aubard, Yves ^b   Preux, Pierre Marie ^c  

^a Dupuytren University Hospital   (France)

^b University Hospital   (Brazil)

^c UF Rech Clinique et Biostatistique   (France)

Author keywords

HBs Ag carrier; Hepatitis B vaccine; Hepatitis B virus; Infant; Mothers

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MARKER; VIRUS DNA; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AFRICA; ARTICLE; CARIBBEAN ISLANDS; CONTROLLED STUDY; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MOTHER; PREGNANCY; PRENATAL SCREENING; PREVALENCE; SCREENING; SOUTHEAST ASIA; UNIVERSITY HOSPITAL; VACCINATION; VIRUS REPLICATION; AFRICA SOUTH OF THE SAHARA; EPIDEMIOLOGY; ETHNOLOGY; PREGNANCY COMPLICATION;

AFRICA SOUTH OF THE SAHARA; ASIA, SOUTHEASTERN; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HOSPITALS, UNIVERSITY; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 7244261971     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10654-004-5755-9     Document Type: Article

References (34)

1. Krugman S. Viral hepatitis: 1985 update. Pediatr Rev 1985; 7: 3-11.
2. Barin F, Goudeau A, Denis F, et al. Immune response in neonates to hepatitis B vaccine. Lancet 1982; 1: 251-253.
3. Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus infections in pre-school children in Taiwan. J Infect Dis 1981; 146: 198-204.
4. Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet 1981; 2: 388-393.
5. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: Final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983; 3: 135-141.
6. Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mother. J Infect Dis 1983; 147: 185-190.
7. Chung WK, Yoo JY, Sun HS, Lee HY, Lee IJ, Kim SM, Prince AM. Prevention of perinatal transmission of hepatitis B virus: A comparison between the efficacy of passive and passive-active immunization in Korea. J Infect Dis 1985; 151: 280-286.
8. Kanai K, Takehiro A, Noto H, et al. Prevention of perinatal transmission of hepatitis B virus (HBV) to children of e antigen-positive HBV carier mothers by hepatitis B immune globulin and HBV vaccine. J Infect Dis 1985; 151: 287-290.
9. Maupas P, Chiron JP, Barin F, et al. Efficacy of hepatitis B vaccine in prevention of early HBs Ag carrier state in children : Controled clinical trial in an endemic area (Senegal). Lancet 1981; 1: 289-292.
10. Reesink HW, Reesink-Brongers EE, Lafeber-Schut BJT, et al. Prevention of chronic HBs Ag carrier state in infants of HBs Ag positive mothers by hepatitis B immunoglobulin. Lancet 1979; 2: 436-438.
11. Schalm SW, Mazel JA, de Gast GC, et al. Prevention of hepatitis B infection in new-borns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics 1989; 83: 1041-1048.
12. Wong VCW, Ip HMH, Reesink HW. Prevention of the HBs Ag carrier state in new-born infants of mothers who are chronic carriers of HBs Ag and HBe Ag by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1987; 1: 921-926.
13. Armitage, P., Berry G. Statistical methods in medical research, 3rd edn. Oxford: Blackwell Scientific Publications, 1994.
14. Denis F, Tabaste JL Ranger-Rogez S and the Multicentric Group. Prevalence of HBs Ag in about 21,500 pregnant women: Survey at 12 French University Hospitals. Pathol Biol 1994; 42: 533-538.
15. Roudot-Thoraval F, Kouadja F, Wirquin V, et al. Prevalence of HBs antigen and markers of B virus replication in a population of pregnant women in France. Gastroentérolog Clin Biol 1989; 13: 353-356.
16. Marib P, Havbold E. Hepatitis B marker incidence pregnancy. Deut Med Wochenschr 1988; 111: 1757-1760.
17. Cunnigham R, North Wood JL, Kelly CD, Box All EH, Andrews NJ. Routine antenatal screening for hepatitis B using pooled sera: Validation and review of 10 years experience. J Clin Pathol 1998; 51: 392-395.
18. Woo D, Cummins M, Davies PA, Harvey DR, Hurley R, Waterson AP. Vertical transmission of hepatitis B surface antigen in carrier mothers in two west London hospitals. Arch Dis Child 1979; 54: 670-675.
19. Goudeau A and the European Regional study group. Epidemiology and eradication strategy for hepatitis B in Europe. Vaccine 1990; 8: 5113-5116.
20. Maniez-Montreuil M, Dupressoir MV, Courroucé A M. Réévaluation de la sensibilité des trousses de dépistage de l'antigène HBs (Ag HBs). Gazette Transfusion 1996; 121: 15-25.
21. Pillonel J, Saura C, Courouce AM. Screening of viral markers for HIV, HBV, and HCV infections in blood donors in France and residual risk of viral transmission by blood transfusion. Euro surveillance 1998; 3: 76-79.
22. Denis F, Goudeau A, Aufrere A. Situation of the hepatitis B vaccination in France in 1996. Bull Soc Pathol Exotique 1998; 91: 37-40.
23. Ranger S, Mounier M, Denis F, Alain J, et al. Prévalence des marqueurs des virus des hépatites B (Ag HBs, Ag HBc, ADN) et delta chez près de dix milles femmes enceintes à Limoges (France). Pathol Biol (Paris) 1990; 38: 694-699.
24. Soulié JC, Goudeau A, Larsen M, Parnet F, et al. Prévention de la transmission périnatale du virus de l'hépatite B. Epidémiologie et rapport coût/efficacité dans la région de Paris. Presse Med 1991; 20: 939-44.
25. Papaevangelou G, Farmaki G, Kada H. Hepatitis B maternal-fetal transmission in Southern Europe. Intervirology 1998; 41: 197-200.
26. Pierce RL, Smith S, Rowe-West B, Sterritt B. Hepatitis B maternal screening, infant vaccination and infant prophylaxis practices in North Carolina. Arch Pediatr Adolescent Med 1999; 153: 619-623.
27. Summers PR, Biswas MK, Pastorek JG, Pernoll ML, Smith LG, Bean BE. The pregnant hepatitis B carrier: Evidence favouring comprehensive antepartum screening. Obstet Gynecol 1987; 69: 701-704.
28. Yusuf HS, Mahoney FJ, Shapiro CN, Maste E, Polish L. Hospital-based evaluation of programs to prevent perinatal hepatitis B virus transmission. Arch Pediat Adol Med 1996; 150: 593-597.
29. Gilbert GL. Prevention of vertical transmission of hepatitis B. The place of routine screening in antenatal care, and the case for immunization of infants at risk. Med J Aust 1984; 141: 213-216.
30. Coleman PF, Jack Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 59: 19-24.
31. Andre F, Zuckerman AJ. Review: Protective efficacy of hepatitis in neonates. J Med Virol 1994; 44: 144-151.
32. Goudeau A, Coursaget P, Barin F, Dubois F, Chiron JP, Denis F, Diop Mar I. Prevention of hepatitis B active and passive immunization. In: "Viral Hepatitis" Szmuness et al. (eds). Philadelphia: The Franklin Institut Presse, 1982: 509-525.
33. Denis F. Controversy on the hepatitis B vaccine. Bull Soc Fr Microbiol 1999; 14: 7-10.
34. Marshall E. A shadow falls on hepatitis B vaccination effort. Science 1998; 281: 630-631.